Debt Load Outpaces Modest Margins
OvervaluedDCF
Equity analysis

Cigna Group (CI) Debt Load Outpaces Modest Margins

Apr 19, 2026Equity Analysis

Can cash and debt stay comfortable at this scale?

Trailing P/E
12.33
Price
278.64
ROE
14.53
Gross Margin
9.3

How Does This Health Insurer Operate?

The Cigna Group is a large U.S. health care company built around insurance and related health services. It serves individuals, employers, and other organizations that purchase coverage and care-management offerings. The business operates at national scale, coordinating benefits and payments across a broad health care network. Its model depends on processing high volumes efficiently across multiple lines of health coverage and services.

Are Revenues Rising Faster Than Profits?

Fundamentals

For 2025 (reported in USD), revenue reached about USD 233.6 billion, growing 16.7% year over year, with EBIT of roughly USD 9.2 billion and net income of about USD 6.3 billion. Profitability stayed slim in percentage terms, with a 3.35% operating margin and a 2.17% net profit margin over the trailing period.

Balance-sheet figures sit alongside that earnings base: cash was around USD 7.7 billion against total debt of roughly USD 31.5 billion. Depreciation and amortization was about USD 2.8 billion, and the cash-flow proxy was near USD 10.5 billion, reflecting operating earnings after tax plus depreciation and amortization, net of capital spending and excluding working-capital changes.

Is The Market Overpricing The Shares?

DCF / Multiples

At USD 278.64 per share, the stock trades well above the DCF fair value range implied by the model’s scenarios. Headline pricing also reads as modest on simple multiples, with a 12.33 P/E and 8.88 EV/EBITDA on a trailing basis, alongside a 0.27 price-to-sales ratio.

High Price With Thin Cushion

Takeaway

The balance sheet carries meaningful debt beside modest cash. Resilience depends on keeping cash generation steady at scale. Thin margins leave less room for operating surprises. If cash softens, funding pressure can rise quickly. The current price looks hard to square with the DCF output.

Disclaimer
This information is for general analytical purposes and is not investment advice.
Fair Value Rankings

Market Price vs Intrinsic Value

Quick access to the most undervalued and overvalued stocks, ranked by their discount or premium to DCF-based fair value.

Undervalued

Stocks trading below fair value

View full ranking
1
Delta Air Lines Inc
DAL
+80%
discount
2
Brown & Brown Inc
BRO
+79%
discount
3
Verizon Communications Inc
VZ
+78%
discount
Overvalued

Stocks trading above fair value

View full ranking
1
Bank of America Corp
BAC
+393%
premium
2
Applied Materials Inc
AMAT
+392%
premium
3
Guidewire Software Inc
GWRE
+391%
premium
INDEX
VDIX
ValueDetect Intrinsic eXpectations Index
Overvalued market
View index

VDIX measures whether the market is expensive or cheap relative to intrinsic value. For each company, ValueDetect estimates fair value using a discounted cash flow (DCF) model, then compares it with the current share price to derive a RiskRatio. These signals are capped, weighted by market capitalization, and aggregated into a single market-wide score.

Current score-0.82Negative = market trades above fair value
1-day move-0.13Rising score = improving valuation conditions
7-day average-0.68Smoothed market valuation signal
Latest observation03 June 2026The latest weighted reading suggests that the market is trading above DCF-based intrinsic value in aggregate.
Next actions

What would you like?

Continuously expanding company coverage — prioritized by user demand.

Suggest a company to analyze

Help shape what we analyze next.

We'll send a confirmation email to verify your request — not for marketing.

New analyses are added regularly. Request processing times may vary.